Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8820829 | 0.80 | ALDH1A1 (0.30) | ALDH1A1TDP1 | |
| SCHEMBL439437 | 0.75 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL9324958 | 0.75 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL8819893 | 0.74 | FFAR3 (0.36) | ALDH1A1 | |
| SCHEMBL9810240 | 0.74 | SMN1; SMN2 (0.34) | GRM2GRM3NOS1NOS2NOS3 | |
| SCHEMBL445483 | 0.74 | SMN1; SMN2 (0.34) | GRM2GRM3NOS1NOS2NOS3 | |
| SCHEMBL10421342 | 0.73 | SLC7A5 (0.47) | GRM2GRM3ALDH1A1 | |
| SCHEMBL121974 | 0.73 | SMN1; SMN2 (0.34) | ALDH1A1NOS1NOS2NOS3 | |
| SCHEMBL3921490 | 0.73 | SMN1; SMN2 (0.34) | ALDH1A1NOS1NOS2NOS3 | |
| SCHEMBL4604196 | 0.71 | ALDH1A1 (0.39) | GRM2GRM3ALDH1A1TDP1NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0532595-A1 | THE PHARMACOLOGICAL USE OF CERTAIN CYSTINE DERIVATIVES. | ASTRA AB (SE) | 1993-03-24 | — | — | EP | claimed |
| WO-1991018594-A1 | THE PHARMACOLOGICAL USE OF CERTAIN CYSTINE DERIVATIVES | AKTIEBOLAGET ASTRA (SE) | 1991-12-12 | — | — | WO | claimed |
| WO-1997046229-A1 | NEW USE OF DERIVATIVES OF CYSTINE | ASTRA AKTIEBOLAG (SE) | 1997-12-11 | — | — | WO | disclosed |
| EP-0532595-A1 | THE PHARMACOLOGICAL USE OF CERTAIN CYSTINE DERIVATIVES. | ASTRA AB (SE) | 1993-03-24 | — | — | EP | disclosed |
| WO-1991018594-A1 | THE PHARMACOLOGICAL USE OF CERTAIN CYSTINE DERIVATIVES | AKTIEBOLAGET ASTRA (SE) | 1991-12-12 | — | — | WO | disclosed |